STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
VKTX VIKING THERAPEUTICS StockScouter® Report
2
StockScouter® Score
VIKING THERAPEUTICS, a mid cap company in the healthcare sector, is expected to perform in line with the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
Concerns
- One or more analysts has modestly decreased quarterly earnings estimates for VKTX. Negative
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
- Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a large company like VKTX
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
C
N/A
A